The Helicobacter felis mouse model in assessing anti-Helicobacter therapies and gastric mucosal prostaglandin E2 levels.

Höök-Nikanne, J; Aho, P; Kärkkäinen, P; Kosunen, T U; Salaspuro, M

Höök-Nikanne, J; Aho, P; Kärkkäinen, P; Kosunen, T U; Salaspuro, M.

Affiliation

Höök-Nikanne J; Research Unit of Alcohol Diseases, University of Helsinki, Finland.

Scand J Gastroenterol ; 31(4): 334-8, 1996 Apr.

Article in En | MEDLINE | ID: mdl-8726299

Subject(s)

Dinoprostone/metabolism; Disease Models, Animal; Gastric Mucosa/metabolism; Helicobacter Infections/drug therapy; Helicobacter Infections/metabolism; Amoxicillin/therapeutic use; Animals; Anti-Ulcer Agents/therapeutic use; Catechols/therapeutic use; Drug Therapy, Combination; Erythromycin/therapeutic use; Male; Mice; Mice, Inbred BALB C; Organometallic Compounds/administration & dosage; Pentanones/therapeutic use; Tetracycline/administration & dosage; Tinidazole/administration & dosage

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Dinoprostone / Helicobacter Infections / Disease Models, Animal / Gastric Mucosa Limits: Animals Language: En Journal: Scand J Gastroenterol Year: 1996 Document type: Article Affiliation country: Finland

Search on Google

Add to My VHL

XML

PubMed Links